Hello, Fool! | Login | Signup | My Fool
Dec 4, 2008 2:05 PM ET | Feedback | Site Changes | Help
Life sciences company focused on developing proprietary drugs to treat or prevent cardiovascular diseases. Current efforts are focused on the treatment of atrial arrhythmias and congestive heart failure.
View All Commentary (CRME)
Recs
steelpoker (< 20) Submitted: 2/25/08 7:42 PM : Start Price: $7.37 CRME Score: -9.33
Going to get approved... Good long-term prospects. Got 30% pre-caps, but still a good investment.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK